BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 29258674)

  • 1. Surgical Outcomes After Neoadjuvant Chemotherapy and Ipilimumab for Non-Small Cell Lung Cancer.
    Yang CJ; McSherry F; Mayne NR; Wang X; Berry MF; Tong B; Harpole DH; D'Amico TA; Christensen JD; Ready NE; Klapper JA
    Ann Thorac Surg; 2018 Mar; 105(3):924-929. PubMed ID: 29258674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk associated with bilobectomy after neoadjuvant concurrent chemoradiotherapy for stage IIIA-N2 non-small-cell lung cancer.
    Cho JH; Kim J; Kim K; Shim YM; Kim HK; Choi YS
    World J Surg; 2012 May; 36(5):1199-1205. PubMed ID: 22374538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant Chemoradiation Shows No Survival Advantage to Chemotherapy Alone in Stage IIIA Patients.
    Krantz SB; Mitzman B; Lutfi W; Kuchta K; Wang CH; Howington JA; Kim KW
    Ann Thorac Surg; 2018 Apr; 105(4):1008-1016. PubMed ID: 29453000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial.
    Stupp R; Mayer M; Kann R; Weder W; Zouhair A; Betticher DC; Roth AD; Stahel RA; Majno SB; Peters S; Jost L; Furrer M; Thierstein S; Schmid RA; Hsu-Schmitz SF; Mirimanoff RO; Ris HB; Pless M
    Lancet Oncol; 2009 Aug; 10(8):785-93. PubMed ID: 19604722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
    Nagai K; Tsuchiya R; Mori T; Tada H; Ichinose Y; Koike T; Kato H;
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):254-60. PubMed ID: 12579093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of mediastinal lymph node status and relapse pattern in clinical stage IIIA non-small cell lung cancer patients treated with neoadjuvant chemotherapy versus upfront surgery: A single center experience.
    Savic M; Kontic M; Ercegovac M; Stojsic J; Bascarevic S; Moskovljevic D; Kostic M; Vesovic R; Popevic S; Laban M; Markovic J; Jovanovic D
    Thorac Cancer; 2017 Sep; 8(5):393-401. PubMed ID: 28671758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.
    Pless M; Stupp R; Ris HB; Stahel RA; Weder W; Thierstein S; Gerard MA; Xyrafas A; Früh M; Cathomas R; Zippelius A; Roth A; Bijelovic M; Ochsenbein A; Meier UR; Mamot C; Rauch D; Gautschi O; Betticher DC; Mirimanoff RO; Peters S;
    Lancet; 2015 Sep; 386(9998):1049-56. PubMed ID: 26275735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non-small cell lung cancer.
    Sepesi B; Zhou N; William WN; Lin HY; Leung CH; Weissferdt A; Mitchell KG; Pataer A; Walsh GL; Rice DC; Roth JA; Mehran RJ; Hofstetter WL; Antonoff MB; Rajaram R; Negrao MV; Tsao AS; Gibbons DL; Lee JJ; Heymach JV; Vaporciyan AA; Swisher SG; Cascone T
    J Thorac Cardiovasc Surg; 2022 Nov; 164(5):1327-1337. PubMed ID: 35190177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non-small cell lung cancer.
    Tong BC; Gu L; Wang X; Wigle DA; Phillips JD; Harpole DH; Klapper JA; Sporn T; Ready NE; D'Amico TA
    J Thorac Cardiovasc Surg; 2022 Feb; 163(2):427-436. PubMed ID: 33985811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung cancer.
    Feldman H; Sepesi B; Leung CH; Lin H; Weissferdt A; Pataer A; William WN; Walsh GL; Rice DC; Roth JA; Mehran RJ; Hofstetter WL; Antonoff MB; Rajaram R; Gibbons DL; Lee JJ; Heymach JV; Vaporciyan AA; Swisher SG; Cascone T
    J Thorac Cardiovasc Surg; 2024 Apr; 167(4):1444-1453.e4. PubMed ID: 37816395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morbidity and mortality after induction chemotherapy followed by surgery in IIIa-N2 non small cell lung cancer.
    Borreman P; De Leyn P; Decaluwé H; Moons J; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Acta Chir Belg; 2009; 109(3):333-9. PubMed ID: 19943589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer.
    Yang CF; Adil SM; Anderson KL; Meyerhoff RR; Turley RS; Hartwig MG; Harpole DH; Tong BC; Onaitis MW; D'Amico TA; Berry MF
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1607-13. PubMed ID: 26719403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-Year Survival Among Stage IIIA Lung Cancer Patients Receiving Two Different Treatment Modalities.
    Bilfinger T; Keresztes R; Albano D; Nemesure B
    Med Sci Monit; 2016 Jul; 22():2589-94. PubMed ID: 27442604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of stage IIIA non-small cell lung cancer by thoracic surgeons in North America.
    Veeramachaneni NK; Feins RH; Stephenson BJ; Edwards LJ; Fernandez FG
    Ann Thorac Surg; 2012 Sep; 94(3):922-6; discussion 926-8. PubMed ID: 22742842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumonectomy after neoadjuvant chemotherapy and radiation for advanced-stage lung cancer.
    Ng T; Birnbaum AE; Fontaine JP; Berz D; Safran HP; Dipetrillo TA
    Ann Surg Oncol; 2010 Feb; 17(2):476-82. PubMed ID: 19915918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trial.
    Saka H; Kitagawa C; Ichinose Y; Takenoyama M; Ibata H; Kato T; Takami K; Yamashita M; Maeda T; Takeo S; Ueda H; Okabayashi K; Nagashima S; Oka T; Kouso H; Fukuyama S; Yoshimoto K; Shimokawa M; Saito AM; Ito S
    Trials; 2017 Sep; 18(1):429. PubMed ID: 28915900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0-1 non-small cell lung cancer: the INCREASE trial.
    Dickhoff C; Senan S; Schneiders FL; Veltman J; Hashemi S; Daniels JMA; Fransen M; Heineman DJ; Radonic T; van de Ven PM; Bartelink IH; Meijboom LJ; Garcia-Vallejo JJ; Oprea-Lager DE; de Gruijl TD; Bahce I
    BMC Cancer; 2020 Aug; 20(1):764. PubMed ID: 32795284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative endobronchial photodynamic therapy improves resectability in initially irresectable (inoperable) locally advanced non small cell lung cancer.
    Akopov A; Rusanov A; Gerasin A; Kazakov N; Urtenova M; Chistyakov I
    Photodiagnosis Photodyn Ther; 2014 Sep; 11(3):259-64. PubMed ID: 24704942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study.
    Strauss GM; Herndon JE; Sherman DD; Mathisen DJ; Carey RW; Choi NC; Rege VB; Modeas C; Green MR
    J Clin Oncol; 1992 Aug; 10(8):1237-44. PubMed ID: 1321893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.